Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Corrigendum
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,947 | Dovepress* | 6,845+ | 1,424 | 8,269 | |
PubMed Central* | 102 | 48 | 150 | ||
Totals | 6,947 | 1,472 | 8,419 | ||
*Since 19 April 2017 |
View citations on PubMed Central and Google Scholar